Slide Insurance Holdings, Inc.
For the period ended Jun 30, 2026. Filed Jul 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Jul 30, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-03-31; filed 2026-04-30.
0001193125-26-197194
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationCurrent report: 10-Q
Period ended 2026-06-30; filed 2026-07-30.
0001193125-26-326333
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 8 previous paragraphs and 13 current paragraphs.
5 unchanged; 3 reworded; 5 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 2 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
Our operations and financial results are subject to various risks and uncertainties. There have been no material changes in our risk factors from those previously disclosed in Part 1, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025.
Added paragraphs (5)
Current report
On July 27, 2026, the Company entered into the Third Amendment of the Credit Agreement to, among other things, increase its revolving credit facility to $530.4 million. All other material terms of the Credit Agreement, as amended, remained unchanged.
Current report
There are no material relationships between the Company or any of its subsidiaries or affiliates and the lenders and/or their respective affiliates, other than in respect of the Credit Agreement, Amendment and certain commercial banking and lending relationships, all of which have been entered into in the ordinary course of business.
Current report
On June 12, 2026, the Company’s Chief Executive Officer and the Company's President and Chief Operating Officer, terminated a Rule 10b5-1 trading plan providing for the sale of up to 10 million and 1 million shares of the Company’s common stock and which was adopted on November 21, 2025. The trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The duration of the trading plan was effective until September 16, 2026, or earlier if all transactions under the trading plan were completed.
Reworded paragraphs (3)
Previous wording
The following table presents information related to our repurchases of common stock during the first quarter of 2026:
Current wording
The following table presents information related to our repurchases of common stock during the second quarter of 2026:
Previous wording
On August 26, 2025, the Board authorized the repurchase program, which allows the Company to repurchase, from time to time, up to $75.0 million of common stock through open market repurchases in compliance with Rule 10b-18 under the Exchange Act and/or in privately negotiated transactions at management’s discretion based on market and business conditions, applicable legal requirements and other factors. On November 4, 2025, the Board authorized an increase to the repurchase program to purchase an additional $45.0 million of common stock. On March 23, 2026, the Company had completed its initial $120 million common stock repurchase plan. On March 23, 2026, the Board authorized a new stock repurchase plan, which allows the Company to repurchase, from time to time, up to $125.0 million of common stock through open market repurchases in compliance with Rule 10b-18 under the Exchange Act and/or in privately negotiated transactions at management’s discretion based on market and business conditions, applicable legal requirements and other factors. For the three months ended March 31, 2026, under the repurchase program and the new stock repurchase program, the Company repurchased 7,724,240 shares of common stock for $137.1 million.
Current wording
On August 26, 2025, the Board authorized the repurchase program, which allows the Company to repurchase, from time to time, up to $75.0 million of common stock through open market repurchases in compliance with Rule 10b-18 under the Exchange Act and/or in privately negotiated transactions at management’s discretion based on market and business conditions, applicable legal requirements and other factors. On November 4, 2025, the Board authorized an increase to the repurchase program to purchase an additional $45.0 million of common stock. On March 23, 2026, the Company had completed its initial $120 million common stock repurchase plan. On March 23, 2026, the Board authorized a new stock repurchase plan, which allows the Company to repurchase, from time to time, up to $125.0 million of common stock through open market repurchases in compliance with Rule 10b-18 under the Exchange Act and/or in privately negotiated transactions at management’s discretion based on market and business conditions, applicable legal requirements and other factors. On April 28, 2026, the Board authorized an increase to the repurchase program to purchase an additional $100.0 million of common stock. For the three months ended June 30, 2026, under the repurchase program and the new stock repurchase program, the Company repurchased 2,997,980 shares of common stock for $53.8 million.
Previous wording
Noneof the Company's directors or officers (as defined in Rule 16a-1(f))adopted, modifiedor terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of SEC Regulation S-K) during the quarter ended March 31, 2026, except as described in the table below:
Current wording
Noneof the Company's directors or officers (as defined in Rule 16a-1(f))adopted, modifiedor terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of SEC Regulation S-K) during the quarter ended June 30, 2026, except as described below: